YHLO Biotech

Company Deals

YHLO Biotech and Jingyi Bio Forge Strategic Alliance to Advance Neuroimmunology Diagnostics – Expanding Autoimmune Testing into Neurological Disorders

Fineline Cube Jun 24, 2026

Shenzhen YHLO Biotech Co., Ltd. and Beijing Jingyi Bio have formally signed a comprehensive cooperation...

Company Deals

YHLO Biotech Partners with NCRCID to Develop Advanced Tuberculosis Diagnostics

Fineline Cube Mar 27, 2023

China-based Shenzhen YHLO Biotech Co., Ltd has entered into a strategic partnership with the National...

Company Deals

Shenzhen YHLO Biotech Partners with NCRCID for Advanced Tuberculosis Diagnostics

Fineline Cube Mar 27, 2023

China-based Shenzhen YHLO Biotech Co., Ltd has announced a strategic partnership with the National Clinical...

Company Drug

CARsgen Therapeutics Secures NMPA Clinical Trial Approval for Allogeneic CAR-T Therapy CT1190B in Relapsed/Refractory Large B-Cell Lymphoma

Company Deals

Transcenta and WuXi Biologics Forge Strategic CDMO Partnership with RMB 190 Million Manufacturing Facility Transaction

Company Drug

Takeda Expands Revestive Approval in China with New 1.25 mg Specification for Pediatric Short Bowel Syndrome Patients as Young as 4 Months

Company Drug

Hengrui Pharmaceuticals Secures Fifth NMPA Approval for Ivarmacitinib in Non-Radiographic Axial Spondyloarthritis